Omrix Biopharmaceuticals, Inc. (OMRI)

PrincetonAl (< 20) Submitted: 8/22/06 5:42 PM : Start Price: $15.22 OMRI Score: 5.53

Profitable commercial stage biotech trading at 10x EPS ... more indications coming on line to continue to allow expansion and growth, no analysts are predicted its latest quarter of profitable, its underfollowed for now ... but expect this to pop a good 30% from here. Longer-term there are challenges as always, as the big boys try to lock up market share with umbrella contracts. But that still leaves room for this to move or be acquired.

Report this Post Replies: 0 | Reply